Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. seras_v4.0

SERAS_v4.0 SIGNED

Seizure Risk Asessment for Epilepsy

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 SERAS_v4.0 project word cloud

Explore the words cloud of the SERAS_v4.0 project. It provides you a very rough idea of what is the project "SERAS_v4.0" about.

suffer    65    recorded    27    suffers    treatments    sme    earpiece    people    functionalities    occurs    prediction    business    everybody    caused    diseases    reads    data    worldwide    services    claim    platform    frequency    digital    pathologies    global    patients    serious    artificial    epilepsy    automate    knowing    doctors    consists    turnover    mobile    monitoring    discrete    electroencephalogram    validated    neuroserveis    generation    monitors    seizure    seizures    benchmark    commercialization    minute    wearable    permanent    plan    continuous    market    accelerate    intensity    neurological    predicts    usa    seras    reports    portable    life    care    million    world    containing    accident    ph2    disruptive    2025    invasive    moved    intelligence    create    health    quality    mjn    permanently    source    patient    signals    medical    alerts    solution    suffered    depending    predicting    clinically    connected    brain    vision    time    live    learning    accidents    instrument    environment    cloud    epileptic    monitor    device    social    algorithm   

Project "SERAS_v4.0" data sheet

The following table provides information about the project.

Coordinator		 MJN NEUROSERVEIS SL 

Organization address
address: AVENUE JOAN CARLES 184 PLANTA BJS PUERTA DR
city: BLANES
postcode: 17300
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country Spain [ES]
 Total cost 2˙568˙300 €
 EC max contribution 1˙797˙810 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-2
 Funding Scheme SME-2
 Starting year 2019
 Duration (year-month-day) from 2019-04-01   to  2021-03-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    MJN NEUROSERVEIS SL ES (BLANES) coordinator 1˙797˙810.00

Map

 Project objective

MJN Neuroserveis’ has developed SERAS, a non-invasive, discrete and wearable device that predicts an epileptic seizure before it occurs. The device consists of an earpiece that reads the electroencephalogram, and a cloud-connected mobile application containing an artificial intelligence algorithm that alerts the user, their environment, and medical services one minute before a seizure occurs. In addition, the device permanently monitors a patient's brain activity, allowing for the generation of medical reports, the number of seizures suffered, their intensity and frequency. Currently, doctors who care for these patients do not have the data to allow for targeted patient treatments. Today, there is no device clinically validated in the market with these functionalities that can permanently monitor brain activity in a discrete, portable and continuous way. Around 50-65 million people suffers from epilepsy worldwide, depending on source. These people live in a permanent state of uncertainty, caused by not knowing when they will suffer the next seizure and if it could cause a serious accident for them. SERAS is a disruptive solution unique in monitoring brain signals and predicting epilepsy seizures with enough time to avoid accidents. MJN is a business moved by high social impact vision; our claim is ‘Quality of life for everybody’. We face a market of 6 million epileptic people in EU and USA. We aim to become a new benchmark on a global scale in the digital health world related with neurological diseases. SME Instrument Ph2 project will help us to improve our prediction algorithm in order to automate learning process and create a platform to exploit data recorded from users of the device. This will allow us and doctors go a step further on research of neurological pathologies. By Ph2 project we will accelerate our commercialization plan to scale-up our business to the goal of €27 million turnover by 2025.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SERAS_V4.0" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SERAS_V4.0" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Primavera (2018)

Primavera: immunobiotics for treating early stage Age-related Macular Degeneration (AMD)

Read More  

Woodywood pickering (2019)

Bio-based (fully renewable) cost effective Polymer for new generation of ecological Coatings leveraging a disruptive innovation in the use of Pickering emulsion.

Read More  

MACCO (2019)

Bring social robots into reality with the first real world leading bartender (MACCO)

Read More